BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 28802558)

  • 1. Women, Infants, and Opioids.
    Lowe NK
    J Obstet Gynecol Neonatal Nurs; 2017; 46(5):657-659. PubMed ID: 28802558
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk of neonatal drug withdrawal after intrauterine co-exposure to opioids and psychotropic medications: cohort study.
    Huybrechts KF; Bateman BT; Desai RJ; Hernandez-Diaz S; Rough K; Mogun H; Kerzner LS; Davis JM; Stover M; Bartels D; Cottral J; Patorno E
    BMJ; 2017 Aug; 358():j3326. PubMed ID: 28768628
    [No Abstract]   [Full Text] [Related]  

  • 3. Exposure to prescription opioid analgesics in utero and risk of neonatal abstinence syndrome: population based cohort study.
    Desai RJ; Huybrechts KF; Hernandez-Diaz S; Mogun H; Patorno E; Kaltenbach K; Kerzner LS; Bateman BT
    BMJ; 2015 May; 350():h2102. PubMed ID: 25975601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal Use of Medication for Opioid Use Disorder and Other Prescription Opioids in Cases of Neonatal Opioid Withdrawal Syndrome: North Carolina Medicaid, 2016-2018.
    Austin AE; Bona VD; Cox ME; Proescholdbell S; Fliss MD; Naumann RB
    Am J Public Health; 2021 Sep; 111(9):1682-1685. PubMed ID: 34383554
    [No Abstract]   [Full Text] [Related]  

  • 5. Newborns exposed to opioids need mothers more than NICU, say pediatricians.
    Vogel L
    CMAJ; 2018 Jan; 190(4):E123-E124. PubMed ID: 29378878
    [No Abstract]   [Full Text] [Related]  

  • 6. The opioid epidemic and neonatal abstinence syndrome in the USA: a review of the continuum of care.
    Pryor JR; Maalouf FI; Krans EE; Schumacher RE; Cooper WO; Patrick SW
    Arch Dis Child Fetal Neonatal Ed; 2017 Mar; 102(2):F183-F187. PubMed ID: 28073819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends of Neonatal Abstinence Syndrome Epidemic and Maternal Risk Factors in Florida.
    Wang X; Zhu Y; Dave CV; Alrwisan AA; Voils SA; Winterstein AG
    Pharmacotherapy; 2017 Jul; 37(7):806-813. PubMed ID: 28500694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rural and Urban Differences in Neonatal Abstinence Syndrome and Maternal Opioid Use, 2004 to 2013.
    Villapiano NL; Winkelman TN; Kozhimannil KB; Davis MM; Patrick SW
    JAMA Pediatr; 2017 Feb; 171(2):194-196. PubMed ID: 27942711
    [No Abstract]   [Full Text] [Related]  

  • 9. Statewide Task Force on Prescription Drug Abuse and Newborns Update: Neonatal Abstinence Syndrome Data Summary.
    Fla Nurse; 2015 Jun; 63(2):14. PubMed ID: 26259378
    [No Abstract]   [Full Text] [Related]  

  • 10. A Practical Approach to Neonatal Opiate Withdrawal Syndrome.
    Devlin LA; Davis JM
    Am J Perinatol; 2018 Mar; 35(4):324-330. PubMed ID: 29100261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trajectories of Prescription Opioid Utilization During Pregnancy Among Prepregnancy Chronic Users and Risk of Neonatal Opioid Withdrawal Syndrome.
    Straub L; Huybrechts KF; Hernández-Díaz S; Zhu Y; Vine S; Desai RJ; Gray KJ; Bateman BT
    Am J Epidemiol; 2022 Jan; 191(1):208-219. PubMed ID: 34643225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of Tennessee's Opioid Legislation for Neonatal Abstinence Syndrome.
    Shearer JN; Erwin PC; Davis SK; Anderson JG; Lindley LC
    Policy Polit Nurs Pract; 2019 Aug; 20(3):153-162. PubMed ID: 31390304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioids in pregnancy and neonatal abstinence syndrome.
    Stover MW; Davis JM
    Semin Perinatol; 2015 Nov; 39(7):561-5. PubMed ID: 26452318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Public Health Surveillance of Prenatal Opioid Exposure in Mothers and Infants.
    Honein MA; Boyle C; Redfield RR
    Pediatrics; 2019 Mar; 143(3):. PubMed ID: 30655335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of opioid dependence in the setting of pregnancy.
    Young JL; Martin PR
    Psychiatr Clin North Am; 2012 Jun; 35(2):441-60. PubMed ID: 22640765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of prenatal alcohol co-exposure on neonatal abstinence syndrome in infants born to mothers in opioid maintenance treatment.
    Kreitinger C; Gutierrez H; Hamidovic A; Schmitt C; Sarangarm P; Rayburn WF; Leeman L; Bakhireva LN
    J Matern Fetal Neonatal Med; 2016 Mar; 29(5):783-8. PubMed ID: 25758627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid Exposed Mothers and Infants in Delaware: Clinical and Legal Considerations.
    Savin MK; Paul DA
    Del Med J; 2016 Apr; 88(4):110-4. PubMed ID: 27263243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of Maternal-Risk Factors Related to Neonatal Abstinence Syndrome in a Commercial Claims Database: 2011-2015.
    Dave CV; Goodin A; Zhu Y; Winterstein A; Wang X; Alrwisan A; Hartzema A
    Pharmacotherapy; 2019 Oct; 39(10):1005-1011. PubMed ID: 31361913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of Prenatal Opioid Exposure in Ontario, Canada, 2014-2019.
    Camden A; Ray JG; To T; Gomes T; Bai L; Guttmann A
    JAMA Netw Open; 2021 Feb; 4(2):e2037388. PubMed ID: 33595660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pregnant women with opioid use disorder and their infants in three state Medicaid programs in 2013-2016.
    Clemans-Cope L; Lynch V; Howell E; Hill I; Holla N; Morgan J; Johnson P; Cross-Barnet C; Thompson JA
    Drug Alcohol Depend; 2019 Feb; 195():156-163. PubMed ID: 30677745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.